Literature DB >> 29095728

Effects of Local Low-Dose Alendronate Injections Into the Distraction Gap on New Bone Formation and Distraction Rate on Distraction Osteogenesis.

Yunus Emre Alp1, Alper Taskaldiran, Mustafa Ercument Onder, Siyami Karahan, Ismail Doruk Kocyigit, Fethi Atil, Umut Tekin.   

Abstract

Bisphosphonates that constrain bone resorption have a direct effect on osteoclast function. In this experimental study, the effects of low-dose local alendronate injections on the distraction gap (DG) in rabbit mandible at 2 different rates were evaluated.The experimental study was conducted on 20 male, New Zealand white rabbits. The animals were divided into 3 experimental groups and 1 control group. Group 1 consisted of animals with distraction at the rate of 1 mm/day, receiving postoperative local low-dose alendronate local injections into the DG. Group 2 consisted of animals with distraction at the rate of 2 mm/day, receiving postoperative 0.75 μg/kg of alendronate local injections into the DG. Group 3 consisted of animals with distraction at the rate of 2 mm/day, receiving postoperative 0.2 mL local saline injections into the DG. Group 4 consisted of animals with distraction at the rate of 1 mm/day, receiving postoperative 0.2 mL local saline injections into the DG. All the injections were performed immediately postoperatively and for all groups at 1, 2, 3, and 4 weeks following surgery. The distraction zones were evaluated using dual-energy X-ray absorptiometry and histological analysis.Histologically, bone healing was found to be significantly accelerated in Groups 1 and 4 compared with Groups 2 and 3 (P < 0.05). Bone healing was superior in Group 1 and the difference was statistically significant compared with Group 4. There was a significant increase in mean bone mineral density in the 1 mm daily rate groups (Groups 1 and 4) compared with the 2 mm daily rate groups (Groups 2 and 3) (P < 0.05).Local low-dose alendronate injections could be an effective way for improving bone formation in distraction osteogenesis. Furthermore, the results of this study did not support the hypothesis that injections of local low-dose alendronate may allow 2 mm/day instead of 1 mm/day of elongation in the rabbit mandible.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29095728     DOI: 10.1097/SCS.0000000000002615

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  6 in total

Review 1.  Application of chemical factors for acceleration of consolidation phase of the distraction osteogenesis: a scoping review.

Authors:  Sadra Mohaghegh; Fatemeh Alirezaei; Nima Ahmadi; Farnaz Kouhestani; Saeed Reza Motamedian
Journal:  Oral Maxillofac Surg       Date:  2022-07-19

Review 2.  Overview of Physical and Pharmacological Therapy in Enhancing Bone Regeneration Formation During Distraction Osteogenesis.

Authors:  Ze Liu; Qi Liu; Hongbin Guo; Jieyu Liang; Yi Zhang
Journal:  Front Cell Dev Biol       Date:  2022-04-28

3.  Histopathological Examination of the Effects of Local and Systemic Bisphosphonate Usage in Bone Graft Applications on Bone Healing.

Authors:  Sabit Demircan; S Cemil İşler
Journal:  J Maxillofac Oral Surg       Date:  2020-01-27

4.  The assessment of new bone formation induced by unfocused extracorporeal shock wave therapy applied on pre-surgical phase of distraction osteogenesis.

Authors:  Erman Senel; Enes Ozkan; Mehmet Cihan Bereket; Mehmet Emin Onger
Journal:  Eur Oral Res       Date:  2019-09-01

5.  Effect of local application of biphosphonates on improving peri-implant osseointegration in type-2 diabetic osteoporosis.

Authors:  Xiaoqian Ding; Lan Yang; Yun Hu; Jinfeng Yu; Yu Tang; Dan Luo; Leilei Zheng
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

6.  Effect of bisphosphonate treatment of titanium surfaces on alkaline phosphatase activity in osteoblasts: a systematic review and meta-analysis.

Authors:  Christian Wehner; Stefan Lettner; Andreas Moritz; Oleh Andrukhov; Xiaohui Rausch-Fan
Journal:  BMC Oral Health       Date:  2020-04-25       Impact factor: 2.757

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.